Benproperine

Benproperine

SCHEMBL15251668

CC(COc1ccccc1Cc1ccccc1)N1CCCCC1.[NaH]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 10/20 0.56
DRD1 P21728 7/20 0.56
DRD5 P21918 6/20 0.56
DRD4 P21917 5/20 0.56
DRD3 P35462 5/20 0.56
DRD2 P14416 5/20 0.56
HTR1A P08908 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benproperine SCHEMBL29619460 0.99 HRH1 (0.58) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL28016122 0.99 HRH1 (0.58) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL17660555 0.99 HRH1 (0.58) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL17660552 0.99 HRH1 (0.58) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL142207 0.99 HRH1 (0.58) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL15251665 0.97 HRH1 (0.56) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL15251659 0.97 HRH1 (0.56) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL28399849 0.97 HRH1 (0.56) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL31351271 0.92 HRH1 (0.51) HRH1DRD1DRD5DRD4DRD3
Benproperine SCHEMBL348563 0.92 HRH1 (0.51) HRH1DRD1DRD5DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638910-B1 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2017-07-12 EP claimed
US-8716288-B2 Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-05-06 US claimed
US-20130245068-A1 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-09-19 US claimed
EP-2638910-A2 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES Korea Research Institute of Bioscience and Biotechnology (KR) 2013-09-18 EP claimed
EP-2638910-B1 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2017-07-12 EP disclosed
US-8716288-B2 Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-05-06 US disclosed
US-20130245068-A1 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-09-19 US disclosed
EP-2638910-A2 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES Korea Research Institute of Bioscience and Biotechnology (KR) 2013-09-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245068-A1 COMPOSITION COMPRISING BENPROPERINE DERIVATIVES AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASES KDR, FLT4, FLT1 HRH1 1827/4885DRD1 1940/4885DRD5 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.